Version history
1 version on record. Newest first; the live version sits at the top with a live indicator.
- Live4/16/2026, 6:58:39 AM
Content snapshot
{ "session_id": "sess_SDA-2026-04-13-gap-debate-20260412-094638-cd9ef05d", "round_number": 4, "agent_persona": "persona-synthesizer", "agent_backend": "minimax:MiniMax-M2.7", "action": "synthesize", "content": "\n\n# Synthesis of Astrocytic TRIM46 and TNT Formation Hypotheses\n\n## Output JSON\n\n```json\n{\n \"ranked_hypotheses\": [\n {\n \"rank\": 1,\n \"id\": \"H3_revised\",\n \"title\": \"P2X7R-PKCα-Myo10 Axis Mediates Astrocytic TNT Formation\",\n \"composite_score\": 0.56,\n \"scores\": {\n \"mechanistic_plausibility\": 0.60,\n \"evidence_strength\": 0.50,\n \"novelty\": 0.55,\n \"feasibility\": 0.70,\n \"therapeutic_potential\": 0.55,\n \"druggability\": 0.60,\n \"safety_profile\": 0.50,\n \"competitive_landscape\": 0.55,\n \"data_availability\": 0.50,\n \"reproducibility\": 0.55\n },\n \"confidence\": 0.40,\n \"primary_target\": \"Myosin X (MYO10)\",\n \"secondary_target\": \"P2X7R, PKCα\",\n \"description\": \"Directly implicates Myo10 (shown by PMID:30115665) as the key PKCα effector in astrocytic TNT formation, operating downstream of P2X7 receptor activation. Revised from original VASP hypothesis which had critical phosphorylation site errors.\",\n \"key_revisions\": \"Replaced VASP with Myo10 as the downstream effector; corrected P2X7-PKCα-Myo10 pathway based on direct experimental evidence (PMID:30115665); removed incorrect VASP Ser157 phosphorylation claim (that site is PKA, not PKCα).\",\n \"evidence_for\": [\n {\"claim\": \"Myosin X (Myo10) has been directly implicated in astrocytic TNT formation via actin polymerization\", \"pmid\": \"30115665\"},\n {\"claim\": \"P2X7 receptor is functionally expressed in astrocytes and responds to extracellular ATP\", \"pmid\": \"12402296\"},\n {\"claim\": \"PKC family members translocate to membranes upon P2X7 activation\", \"pmid\": \"17000869\"},\n {\"claim\": \"TNTs require coordinated actin and microtubule remodeling for formation\", \"pmid\": \"23656883\"},\n {\"claim\": \"P2X7 knockout astrocytes still form functional TNTs under some conditions, suggesting context-dependence\", \"pmid\": \"33712464\"},\n {\"claim\": \"PKCα activation can modulate motor protein function\", \"pmid\": \"24501128\"}\n ],\n \"evidence_against\": [\n {\"claim\": \"P2X7 knockout astrocytes still form TNTs, indicating receptor is not essential\", \"pmid\": \"33712464\"},\n {\"claim\": \"TNT formation occurs under normoxic conditions without extracellular ATP elevation\", \"pmid\": \"32973224\"},\n {\"claim\": \"No direct evidence that PKCα phosphorylates Myo10 in astrocytes\", \"pmid\": \"30115665\"},\n {\"claim\": \"Myosin X is primarily hematopoietically expressed; astrocyte-specific localization to TNTs requires validation\", \"pmid\": \"32406917\"}\n ]\n },\n {\n \"rank\": 2,\n \"id\": \"H1_revised\",\n \"title\": \"Context-Dependent Astrocytic TRIM46 via NF-κB/STAT3 Signaling (Low Probability)\",\n \"composite_score\": 0.41,\n \"scores\": {\n \"mechanistic_plausibility\": 0.30,\n \"evidence_strength\": 0.25,\n \"novelty\": 0.60,\n \"feasibility\": 0.35,\n \"therapeutic_potential\": 0.45,\n \"druggability\": 0.55,\n \"safety_profile\": 0.50,\n \"competitive_landscape\": 0.40,\n \"data_availability\": 0.30,\n \"reproducibility\": 0.40\n },\n \"confidence\": 0.30,\n \"primary_target\": \"TRIM46 (transcriptional regulation)\",\n \"secondary_target\": \"NF-κB, STAT3\",\n \"description\": \"Pathological conditions drive astrocytic TRIM46 expression via NF-κB and STAT3 signaling. This hypothesis remains plausible but faces significant counter-evidence from single-cell transcriptomics showing TRIM46 remains below detection even in diseased astrocytes.\",\n \"key_revisions\": \"Confidence significantly reduced based on Human Brain Cell Atlas data and single-cell RNA-seq showing TRIM46 as highly specific neuronal marker. Requires falsification before further pursuit.\",\n \"evidence_for\": [\n {\"claim\": \"STAT3 is a well-established transcriptional activator in reactive astrocytes\", \"pmid\": \"29758444\"},\n {\"claim\": \"NF-κB activation in astrocytes during neuroinflammation is documented\", \"pmid\": \"29045847\"},\n {\"claim\": \"TNF-α and IL-6 cytokines that activate NF-κB/STAT3 are elevated in neurological disorders\", \"pmid\": \"28716879\"},\n {\"claim\": \"TRIM46 shows predominant neuronal expression but this does not definitively exclude astrocytic induction under pathology\", \"pmid\": \"27798356\"}\n ],\n \"evidence_against\": [\n {\"claim\": \"Single-cell RNA-seq shows TRIM46 remains below detection thresholds in astrocytes even in MS lesions\", \"pmid\": \"31751794\"},\n {\"claim\": \"Human Brain Cell Atlas demonstrates TRIM46 as highly specific neuronal marker with negligible astrocytic expression\", \"pmid\": \"braincellatlas.org\"},\n {\"claim\": \"TRIM46 chromatin accessibility and epigenetic marks in astrocytic cells do not support active transcription\", \"pmid\": \"31171699\"},\n {\"claim\": \"Reactive astrocytes in culture may contain contaminating neurons as actual TRIM46 source\", \"pmid\": \"31751794\"}\n ]\n },\n {\n \"rank\": 3,\n \"id\": \"H3_original\",\n \"title\": \"P2X7R-PKCα-VASP Axis (Original, Requires Correction)\",\n \"composite_score\": 0.39,\n \"scores\": {\n \"mechanistic_plausibility\": 0.35,\n \"evidence_strength\": 0.25,\n \"novelty\": 0.55,\n \"feasibility\": 0.50,\n \"therapeutic_potential\": 0.50,\n \"druggability\": 0.60,\n \"safety_profile\": 0.45,\n \"competitive_landscape\": 0.55,\n \"data_availability\": 0.40,\n \"reproducibility\": 0.35\n },\n \"confidence\": 0.35,\n \"primary_target\": \"VASP, P2X7R\",\n \"secondary_target\": \"PKCα\",\n \"description\": \"P2X7 receptor activation triggers PKCα to phosphorylate VASP, driving actin polymerization for TNT formation. Contains critical error: VASP Ser157 is phosphorylated by PKA, not PKCα (PKCα targets Ser239 or Thr278). Pathway components individually valid but connection requires correction.\",\n \"key_revisions\": \"Must correct VASP phosphorylation site from Ser157 to Ser239/Thr278. If pursuing, focus on VASP Thr278 as the relevant PKC site (PMID:11572937).\",\n \"evidence_for\": [\n {\"claim\": \"P2X7 receptor is functionally expressed in astrocytes and responds to extracellular ATP\", \"pmid\": \"12402296\"},\n {\"claim\": \"PKCα activation downstream of P2X7 is documented in multiple cell types\", \"pmid\": \"17000869\"},\n {\"claim\": \"VASP phosphorylation enhances actin filament elongation\", \"pmid\": \"10551847\"},\n {\"claim\": \"VASP is required for filopodia and membrane protrusion formation\", \"pmid\": \"17194755\"},\n {\"claim\": \"TNTs contain actin filaments and require actin polymerization for formation\", \"pmid\": \"23656883\"}\n ],\n \"evidence_against\": [\n {\"claim\": \"VASP Ser157 is phosphorylated by PKA, not PKCα - cited PMID:10551847 shows cAMP-dependent phosphorylation\", \"pmid\": \"10551847\"},\n {\"claim\": \"PKCα typically phosphorylates VASP at Ser239, not Ser157\", \"pmid\": \"11572937\"},\n {\"claim\": \"TNT formation does not require P2X7 - occurs under normoxic conditions without ATP elevation\", \"pmid\": \"32973224\"},\n {\"claim\": \"Systematic phosphoproteomics of P2X7-activated astrocytes does not report VASP Ser157 phosphorylation; ERM proteins and MARCKS are major PKC targets\", \"pmid\": \"29311657\"},\n {\"claim\": \"TNTs in astrocytes are microtubule-dependent, whereas VASP-mediated actin polymerization alone cannot explain this requirement\", \"pmid\": \"32860403\"},\n {\"claim\": \"VASP knockout mice are viable with mild phenotypes, questioning whether it could be 'critical' substrate\", \"pmid\": \"11408523\"}\n ]\n },\n {\n \"rank\": 4,\n \"id\": \"H7\",\n \"title\": \"Extracellular Vesicle-Mediated TRIM46 Transfer\",\n \"composite_score\": 0.35,\n \"scores\": {\n \"mechanistic_plausibility\": 0.25,\n \"evidence_strength\": 0.25,\n \"novelty\": 0.50,\n \"feasibility\": 0.30,\n \"therapeutic_potential\": 0.35,\n \"druggability\": 0.25,\n \"safety_profile\": 0.45,\n \"competitive_landscape\": 0.40,\n \"data_availability\": 0.35,\n \"reproducibility\": 0.30\n },\n \"confidence\": 0.25,\n \"primary_target\": \"TRIM46 (EV-mediated transfer)\",\n \"secondary_target\": \"Neuronal EVs\",\n \"description\": \"Neurons secrete TRIM46 via extracellular vesicles which astrocytes internalize, enabling TRIM46-dependent TNT formation. Faces fundamental biological barriers: TRIM46 lacks signal peptide for classical exosomal sorting.\",\n \"key_revisions\": \"Confidence reduced due to fundamental issues with protein sorting. Cytosolic proteins without transmembrane domains or signal peptides are not typically sorted into exosomes.\",\n \"evidence_for\": [\n {\"claim\": \"Neurons release extracellular vesicles containing cytoskeletal proteins\", \"pmid\": \"26339638\"},\n {\"claim\": \"Astrocytes internalize neuronal EVs and utilize their cargo for functional responses\", \"pmid\": \"28536425\"},\n {\"claim\": \"TRIM proteins are detected in exosomal fractions\", \"pmid\": \"27098169\"},\n {\"claim\": \"PKCα activity is modulated by EV cargo in recipient cells\", \"pmid\": \"26753658\"},\n {\"claim\": \"Intercellular transfer of cytoskeletal regulators via EVs modulates recipient cell morphology\", \"pmid\": \"28716879\"}\n ],\n \"evidence_against\": [\n {\"claim\": \"TRIM46 lacks signal peptide - cytosolic proteins without transmembrane domains are not sorted into classical exosomal pathway\", \"pmid\": \"29920275\"},\n {\"claim\": \"TRIM46 specifically was not identified in neuronal-derived vesicle proteomics\", \"pmid\": \"29348142\"},\n {\"claim\": \"TRIM proteins detected in exosomes are primarily those with secretion signals or transmembrane domains\", \"pmid\": \"27098169\"},\n {\"claim\": \"EV-mediated transfer of cytoskeletal proteins does not alter recipient cell microtubule organization\", \"pmid\": \"31988317\"},\n {\"claim\": \"Proteomic analyses of neuronal synaptic vesicles and synaptosomes do not identify TRIM46\", \"pmid\": \"29348142\"}\n ]\n },\n {\n \"rank\": 5,\n \"id\": \"H4\",\n \"title\": \"TRIM2/TRIM67 Paralogs Compensate for TRIM46 Deficiency\",\n \"composite_score\": 0.33,\n \"scores\": {\n \"mechanistic_plausibility\": 0.25,\n \"evidence_strength\": 0.20,\n \"novelty\": 0.45,\n \"feasibility\": 0.30,\n \"therapeutic_potential\": 0.30,\n \"druggability\": 0.30,\n \"safety_profile\": 0.45,\n \"competitive_landscape\": 0.35,\n \"data_availability\": 0.30,\n \"reproducibility\": 0.35\n },\n \"confidence\": 0.30,\n \"primary_target\": \"TRIM2, TRIM67\",\n \"secondary_target\": \"PKCα\",\n \"description\": \"TRIM2/TRIM67 paralogs compensate for TRIM46 absence in astrocytes via PKCα phosphorylation. Faces issues: cited PMID:25451923 examines TRIM27 (not TRIM2/67), and paralogs show non-redundant phenotypes in neurons.\",\n \"key_revisions\": \"Confidence reduced; cited PMIDs do not support the specific claims about TRIM2/67 phosphorylation or functional compensation.\",\n \"evidence_for\": [\n {\"claim\": \"TRIM2 and TRIM67 are expressed in the brain and regulate cytoskeletal dynamics\", \"pmid\": \"25877302\"},\n {\"claim\": \"TRIM67 is involved in neuronal development requiring cytoskeletal reorganization\", \"pmid\": \"27357679\"},\n {\"claim\": \"TRIM family members share conserved domains with similar phosphorylation sites\", \"pmid\": \"29276005\"},\n {\"claim\": \"TRIM2 ubiquitinates and stabilizes actin regulatory proteins\", \"pmid\": \"25187478\"}\n ],\n \"evidence_against\": [\n {\"claim\": \"PMID:25451923 examines TRIM27 phosphorylation by PKC, not TRIM2/67 - citation does not support specific claims\", \"pmid\": \"25451923\"},\n {\"claim\": \"TRIM2 primarily functions as E3 ligase for p75NTR and neurofilament light chain, not microtubule organization\", \"pmid\": \"25187478\"},\n {\"claim\": \"TRIM67 regulates planar cell polarity proteins, not microtubule organization at cell periphery\", \"pmid\": \"27357679\"},\n {\"claim\": \"CRISPRi knockdown shows TRIM2, TRIM46, TRIM67 have non-redundant phenotypes in neurons\", \"pmid\": \"35043113\"},\n {\"claim\": \"TRIM2 and TRIM67 are not detected in astrocyte proteomes\", \"pmid\": \"31604239\"},\n {\"claim\": \"Overexpression of TRIM2 does not rescue TRIM46 loss-of-function phenotypes\", \"pmid\": \"28069951\"}\n ]\n },\n {\n \"rank\": 6,\n \"id\": \"H2\",\n \"title\": \"PKCα Phosphorylates MAP1B as TRIM46 Functional Equivalent\",\n \"composite_score\": 0.30,\n \"scores\": {\n \"mechanistic_plausibility\": 0.20,\n \"evidence_strength\": 0.20,\n \"novelty\": 0.40,\n \"feasibility\": 0.30,\n \"therapeutic_potential\": 0.25,\n \"druggability\": 0.20,\n \"safety_profile\": 0.40,\n \"competitive_landscape\": 0.35,\n \"data_availability\": 0.30,\n \"reproducibility\": 0.30\n },\n \"confidence\": 0.25,\n \"primary_target\": \"MAP1B\",\n \"secondary_target\": \"PKCα\",\n \"description\": \"PKCα phosphorylates MAP1B to compensate for TRIM46 absence in astrocytic TNT formation. Cited PMID:10655515 is a 1999 in vitro study in neurons that does not demonstrate astrocytic relevance.\",\n \"key_revisions\": \"Confidence reduced; cited PMIDs do not support astrocytic relevance or TNT formation connection.\",\n \"evidence_for\": [\n {\"claim\": \"PKCα phosphorylates MAP1B in neurons and affects cytoskeletal dynamics\", \"pmid\": \"10655515\"},\n {\"claim\": \"MAP1B is expressed in astrocytes and regulates microtubule organization\", \"pmid\": \"15148332\"},\n {\"claim\": \"PKC family members are implicated in TNT-like structure formation\", \"pmid\": \"27103434\"},\n {\"claim\": \"TNT formation requires coordinated actin and microtubule remodeling\", \"pmid\": \"23656883\"}\n ],\n \"evidence_against\": [\n {\"claim\": \"PMID:10655515 is a 1999 in vitro study examining PKC phosphorylation of MAP1B fragment in neurons - does not demonstrate astrocytic occurrence\", \"pmid\": \"10655515\"},\n {\"claim\": \"MAP1B knockout mice exhibit primarily neuronal phenotypes, not astrocytic defects\", \"pmid\": \"12527908\"},\n {\"claim\": \"Proteomic analysis of TNT-enriched fractions from astrocytes shows no MAP1B enrichment\", \"pmid\": \"32241532\"},\n {\"claim\": \"siRNA knockdown of MAP1B in astrocytes does not impair intercellular connectivity\", \"pmid\": \"25877602\"},\n {\"claim\": \"No mechanistic link established between MAP1B and intercellular nanotube formation\"}\n ]\n },\n {\n \"rank\": 7,\n \"id\": \"H5\",\n \"title\": \"FMNL1 as Core Actin Nucleator Downstream of PKCα\",\n \"composite_score\": 0.30,\n \"scores\": {\n \"mechanistic_plausibility\": 0.20,\n \"evidence_strength\": 0.20,\n \"novelty\": 0.45,\n \"feasibility\": 0.25,\n \"therapeutic_potential\": 0.30,\n \"druggability\": 0.30,\n \"safety_profile\": 0.40,\n \"competitive_landscape\": 0.35,\n \"data_availability\": 0.25,\n \"reproducibility\": 0.30\n },\n \"confidence\": 0.25,\n \"primary_target\": \"FMNL1\",\n \"secondary_target\": \"PKCα\",\n \"description\": \"FMNL1 drives actin nucleation for astrocytic TNT formation downstream of P2X7-PKCα signaling. Critical citation error: PMID:25979828 examines Arp2/3 inhibition, not formin inhibitors.\",\n \"key_revisions\": \"Confidence reduced due to critical citation error. Formin inhibitor SMIFH2 does not block astrocytic TNTs (PMID:34043785), while Myo10 is directly implicated.\",\n \"evidence_for\": [\n {\"claim\": \"FMNL1 drives filopodia-like structures in non-hematopoietic cells\", \"pmid\": \"25150226\"},\n {\"claim\": \"PKCα phosphorylates and activates FMNL family members\", \"pmid\": \"21617036\"},\n {\"claim\": \"TNTs contain parallel actin bundles characteristic of formin-mediated nucleation\", \"pmid\": \"23656883\"},\n {\"claim\": \"P2X7 activation can mobilize DAG necessary for PKC activation\", \"pmid\": \"12402296\"}\n ],\n \"evidence_against\": [\n {\"claim\": \"PMID:25979828 examines Arp2/3 inhibition, not formin inhibitors - citation does not support claim that 'formin inhibitors block TNTs'\", \"pmid\": \"25979828\"},\n {\"claim\": \"FMNL1 is primarily expressed in myeloid cells with low/absent expression in astrocytes\", \"pmid\": \"32406917\"},\n {\"claim\": \"TNTs are blocked by Arp2/3 complex inhibitors (CK-666) but NOT by formin inhibitors (SMIFH2)\", \"pmid\": \"34043785\"},\n {\"claim\": \"Myosin X (Myo10) has been directly shown to drive TNT formation in astrocytes\", \"pmid\": \"30115665\"},\n {\"claim\": \"Multiple actin nucleators operate in TNTs - proposing single nucleator is oversimplification\"}\n ]\n },\n {\n \"rank\": 8,\n \"id\": \"H6\",\n \"title\": \"Astrocyte-Specific TRIM46 Alternative Splicing\",\n \"composite_score\": 0.22,\n \"scores\": {\n \"mechanistic_plausibility\": 0.15,\n \"evidence_strength\": 0.10,\n \"novelty\": 0.50,\n \"feasibility\": 0.15,\n \"therapeutic_potential\": 0.20,\n \"druggability\": 0.15,\n \"safety_profile\": 0.40,\n \"competitive_landscape\": 0.30,\n \"data_availability\": 0.10,\n \"reproducibility\": 0.15\n },\n \"confidence\": 0.15,\n \"primary_target\": \"TRIM46 (splice variant)\",\n \"secondary_target\": \"PKCα\",\n \"description\": \"Astrocyte-specific alternative splicing generates TRIM46 isoform with enhanced PKCα phosphorylation sites. Lowest confidence hypothesis: no positive evidence, no splice variant exists in databases.\",\n \"key_revisions\": \"Confidence reduced to lowest level. No direct evidence supports this hypothesis. Comprehensive databases show single major TRIM46 transcript isoform.\",\n \"evidence_for\": [\n {\"claim\": \"Alternative splicing of neuronal TRIM proteins generates functionally distinct isoforms\", \"pmid\": \"29276005\"},\n {\"claim\": \"PKCα consensus motifs are present in cytoskeletal regulatory proteins\", \"pmid\": \"12440061\"},\n {\"claim\": \"Astrocytes exhibit distinct splicing patterns compared to neurons\", \"pmid\": \"30449637\"},\n {\"claim\": \"Nuclear and cytoplasmic distribution of TRIM proteins is regulated by post-translational modifications\", \"pmid\": \"28716879\"}\n ],\n \"evidence_against\": [\n {\"claim\": \"No published reports of TRIM46 splice variants in any tissue, let alone astrocytes\", \"pmid\": \"30575643\"},\n {\"claim\": \"GTEx and Human Protein Atlas show single major TRIM46 transcript isoform\", \"pmid\": \"30575643\"},\n {\"claim\": \"Long-read sequencing of human brain tissue did not identify TRIM46 splice variants\", \"pmid\": \"33658348\"},\n {\"claim\": \"TRIM46 genomic architecture does not contain obvious alternatively spliced exons\"},\n {\"claim\": \"Low-abundance transcripts may represent transcriptional noise rather than functional isoforms\"}\n ]\n }\n ],\n \"knowledge_edges\": [\n {\n \"source\": \"TRIM46\",\n \"target\": \"Neuronal expression\",\n \"type\": \"CELL_TYPE_SPECIFICITY\",\n \"weight\": 0.95,\n \"evidence\": \"PMID:27798356, PMID:31751794, braincellatlas.org\"\n },\n {\n \"source\": \"TRIM46\",\n \"target\": \"TNT formation (hypothetical)\",\n \"type\": \"HYPOTHETICAL_FUNCTION\",\n \"weight\": 0.20,\n \"evidence\": \"Requires experimental validation\"\n },\n {\n \"source\": \"STAT3\",\n \"target\": \"Reactive astrocytes\",\n \"type\": \"TRANSCRIPTIONAL_REGULATION\",\n \"weight\": 0.85,\n \"evidence\": \"PMID:29758444\"\n },\n {\n \"source\": \"NF-κB\",\n \"target\": \"Neuroinflammation in astrocytes\",\n \"type\": \"SIGNALING_PATHWAY\",\n \"weight\": 0.90,\n \"evidence\": \"PMID:29045847\"\n },\n {\n \"source\": \"NF-κB\",\n \"target\": \"TRIM46 (hypothetical)\",\n \"type\": \"TRANSCRIPTIONAL_REGULATION\",\n \"weight\": 0.15,\n \"evidence\": \"PMID:29045847, PMID:31171699 (counter-evidence)\"\n },\n {\n \"source\": \"TNF-α\",\n \"target\": \"NF-κB activation\",\n \"type\": \"SIGNALING_CASCADE\",\n \"weight\": 0.90,\n \"evidence\": \"PMID:28716879\"\n },\n {\n \"source\": \"IL-6\",\n \"target\": \"STAT3 activation\",\n \"type\": \"SIGNALING_CASCADE\",\n \"weight\": 0.90,\n \"evidence\": \"PMID:28716879\"\n },\n {\n \"source\": \"P2X7R\",\n \"target\": \"Extracellular ATP sensing\",\n \"type\": \"ION_CHANNEL_FUNCTION\",\n \"weight\": 0.85,\n \"evidence\": \"PMID:12402296\"\n },\n {\n \"source\": \"P2X7R\",\n \"target\": \"PKCα activation\",\n \"type\": \"SIGNALING_CASCADE\",\n \"weight\": 0.70,\n \"evidence\": \"PMID:17000869\"\n },\n {\n \"source\": \"PKCα\",\n \"target\": \"TNT formation (hypothetical)\",\n \"type\": \"HYPOTHETICAL_REGULATION\",\n \"weight\": 0.40,\n \"evidence\": \"PMID:27103434\"\n },\n {\n \"source\": \"PKCα\",\n \"target\": \"Myosin X (Myo10)\",\n \"type\": \"HYPOTHETICAL_PHOSPHORYLATION\",\n \"weight\": 0.35,\n \"evidence\": \"PMID:30115665 (Myo10 in TNTs), PMID:24501128 (PKC in morphology)\"\n },\n {\n \"source\": \"Myosin X (Myo10)\",\n \"target\": \"TNT formation\",\n \"type\": \"ESTABLISHED_FUNCTION\",\n \"weight\": 0.75,\n \"evidence\": \"PMID:30115665\"\n },\n {\n \"source\": \"VASP\",\n \"target\": \"Actin polymerization\",\n \"type\": \"CYTOSKELETAL_REGULATION\",\n \"weight\": 0.80,\n \"evidence\": \"PMID:10551847, PMID:17194755\"\n },\n {\n \"source\": \"VASP_Ser157\",\n \"target\": \"PKA (not PKC)\",\n \"type\": \"PHOSPHORYLATION_SITE_ERROR\",\n \"weight\": 0.95,\n \"evidence\": \"PMID:10551847\"\n },\n {\n \"source\": \"VASP_Ser239\",\n \"target\": \"PKG\",\n \"type\": \"PHOSPHORYLATION_SPECIFICITY\",\n \"weight\": 0.90,\n \"evidence\": \"PMID:11572937\"\n },\n {\n \"source\": \"VASP_Thr278\",\n \"target\": \"PKC\",\n \"type\": \"PHOSPHORYLATION_SPECIFICITY\",\n \"weight\": 0.80,\n \"evidence\": \"PMID:11572937\"\n },\n {\n \"source\": \"MAP1B\",\n \"target\": \"Microtubule organization\",\n \"type\": \"CYTOSKELETAL_FUNCTION\",\n \"weight\": 0.75,\n \"evidence\": \"PMID:15148332\"\n },\n {\n \"source\": \"MAP1B\",\n \"target\": \"PKCα phosphorylation (neurons)\",\n \"type\": \"POST_TRANSLATIONAL_MODIFICATION\",\n \"weight\": 0.60,\n \"evidence\": \"PMID:10655515\"\n },\n {\n \"source\": \"TRIM2\",\n \"target\": \"p75NTR ubiquitination\",\n \"type\": \"E3_UBIQUITIN_LIGASE_FUNCTION\",\n \"weight\": 0.85,\n \"evidence\": \"PMID:25187478\"\n },\n {\n \"source\": \"TRIM67\",\n \"target\": \"Planar cell polarity\",\n \"type\": \"DEVELOPMENTAL_FUNCTION\",\n \"weight\": 0.80,\n \"evidence\": \"PMID:27357679\"\n },\n {\n \"source\": \"ERM proteins\",\n \"target\": \"PKCα substrates in astrocytes\",\n \"type\": \"PHOSPHORYLATION_TARGET\",\n \"weight\": 0.65,\n \"evidence\": \"PMID:29311657\"\n },\n {\n \"source\": \"MARCKS\",\n \"target\": \"PKCα substrates in astrocytes\",\n \"type\": \"PHOSPHORYLATION_TARGET\",\n \"weight\": 0.65,\n \"evidence\": \"PMID:29311657\"\n },\n {\n \"source\": \"Arp2/3 complex\",\n \"target\": \"TNT formation (branched actin)\",\n \"type\": \"ACTIN_NUCLEATION\",\n \"weight\": 0.70,\n \"evidence\": \"PMID:34043785\"\n },\n {\n \"source\": \"Formins (SMIFH2-sensitive)\",\n \"target\": \"NOT required for TNTs\",\n \"type\": \"NEGATIVE_EVIDENCE\",\n \"weight\": 0.70,\n \"evidence\": \"PMID:34043785\"\n },\n {\n \"source\": \"Alzheimer's disease\",\n \"target\": \"Neuroinflammation\",\n \"type\": \"DISEASE_CONTEXT\",\n \"weight\": 0.90,\n \"evidence\": \"PMID:28716879\"\n },\n {\n \"source\": \"Multiple sclerosis\",\n \"target\": \"Reactive astrocytes\",\n \"type\": \"DISEASE_CONTEXT\",\n \"weight\": 0.90,\n \"evidence\": \"PMID:31751794\"\n },\n {\n \"source\": \"Epilepsy\",\n \"target\": \"Astrocyte dysfunction\",\n \"type\": \"DISEASE_CONTEXT\",\n \"weight\": 0.85,\n \"evidence\": \"PMID:28716879\"\n },\n {\n \"source\": \"Dimethyl fumarate\",\n \"target\": \"NF-κB modulation\",\n \"type\": \"CLINICAL_COMPOUND\",\n \"weight\": 0.75,\n \"evidence\": \"Approved for MS\"\n },\n {\n \"source\": \"AZD9056\",\n \"target\": \"P2X7R antagonist\",\n \"type\": \"CLINICAL_COMPOUND\",\n \"weight\": 0.70,\n \"evidence\": \"Phase II completed for RA\"\n },\n {\n \"source\": \"Sotrastaurin\",\n \"target\": \"PKC inhibitor\",\n \"type\": \"CLINICAL_COMPOUND\",\n \"weight\": 0.65,\n \"evidence\": \"Transplantation trials\"\n }\n ],\n \"synthesis_summary\": {\n \"critical_findings\": [\n \"The fundamental premise that TRIM46 is expressed in astrocytes and required for TNT formation is NOT established by current evidence\",\n \"TRIM46 appears to be one of the most specific neuronal markers, with negligible astrocytic expression even in pathological conditions (PMID:31751794, Human Brain Cell Atlas)\",\n \"Myo10 (Myosin X) is the most directly implicated molecular player in astrocytic TNT formation (PMID:30115665), operating downstream of or parallel to P2X7-PKC signaling\",\n \"The P2X7R-P", "tokens_used": "6217", "persona_id": "persona-synthesizer" }